Core Laboratories (CLB) Tops Q4 EPS by 1c, Offers Q1 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall St set for higher open as Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts CLB Hot Sheet
Price: $9.77 --0%
Financial Fact:
Other (income), net: -288K
Today's EPS Names:
ATS, SICP, FTCO, More
Financial Fact:
Other (income), net: -288K
Today's EPS Names:
ATS, SICP, FTCO, More
Join SI Premium – FREE
Core Laboratories (NYSE: CLB) reported Q4 EPS of $0.38, $0.01 better than the analyst estimate of $0.37. Revenue for the quarter came in at $156.8 million versus the consensus estimate of $156.04 million.
GUIDANCE:
Core Laboratories sees Q1 2020 EPS of $0.39-$0.41, versus the consensus of $0.39. Core Laboratories sees Q1 2020 revenue of $159-164 million, versus the consensus of $159.4 million.
For earnings history and earnings-related data on Core Laboratories (CLB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Southwest Gas (SWX) Tops Q3 EPS by 2c; Offers Guidance
- SmartRent (SMRT) Reports In-Line Q3 EPS
- Harmony Biosciences (HRMY) Misses Q3 EPS by 30c; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
